Vident Investment Advisory’s QIAGEN NV QGENF Stock Holding History

Vident Investment Advisory’s Portfolio QGENF Stock Details QGENF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-37,572	Closed	-$1.03M	–	412
2016 Q3	$1.03M	Sell	37,572 -3,762	-9%	-$103K	0.14%	279
2016 Q2	$901K	Sell	41,334 -135,934	-77%	-$2.96M	0.13%	282
2016 Q1	$3.96K	Buy	177,268 +91,609	+107%	+$2.05K	0.24%	209
2015 Q4	$2.37M	Buy	85,659 +15,685	+22%	+$434K	0.3%	47
2015 Q3	$1.8M	Sell	69,974 -20,458	-23%	-$528K	0.25%	108
2015 Q2	$2.24M	Buy	+90,432	New	+$2.24M	0.3%	60

Other funds holding QGENF

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

MNA

Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return

HJGA

Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vident Investment Advisory's QGENF Position: Q4 2016 in Review

Vident Investment Advisory sold out of QIAGEN NV (QGENF) in Q4 2016, closing a stake of 37,572 shares — an estimated $1.03M sold.

Vident Investment Advisory first reported a position in QGENF in Q2 2015 and held it in 6 quarters. The position peaked at $2.37M in Q4 2015. 189 funds tracked by Wall St. Rank hold QGENF as of Q4 2016.

Vident Investment Advisory reported no remaining QIAGEN NV position as of Q4 2016 after selling out during the quarter.
Vident Investment Advisory sold 37,572 QIAGEN NV shares in Q4 2016, an estimated $1.03M.
Vident Investment Advisory first reported a position in QIAGEN NV in Q2 2015 and held it in 6 quarters.
Vident Investment Advisory's QIAGEN NV position peaked at $2.37M in Q4 2015.
189 funds tracked by Wall St. Rank held QIAGEN NV as of Q4 2016.

Based on Vident Investment Advisory's 13F filing for Q4 2016, filed 14 Feb 2017.